Clinical trial
Efficacy of Empagliflozin in Patients With Heart Failure and Atrial Fibrillation
NCT04583813 is registered in ClinicalTrials.gov with Miulli General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Empagliflozin in Patients With Heart Failure and Atrial Fibrillation
- Lead sponsor
- Miulli General Hospital
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- September 30, 2021
- Completion date
- April 30, 2024
- Enrollment
- 400 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.